Furthermore, studies in humans indicate that blocking TLR7 and TLR8 can reduce IFNα production by peripheral blood mononuclear cells (PBMCs) stimulated with SLE immune complexes (15, 18). Here, TLR8 is linked to systemic lupus erythematosus.